Phase III Trial Comparing XELOX Regimen (Oxaliplatin Plus Capecitabine) Versus EOX Regimen (Epirubicin, Oxaliplatin and Capecitabine) as First-Line Treatment for Advanced Gastric Cancer: The EXELOX Trial

Xiaodong Zhu, Weijian Guo, Jieer Ying et al.|SSRN Electronic Journal|2021

Cited by 1